Newstral
Brian Abrahams
- Hospital use reveals the moral high ground in the Israel-Hamas war | GUEST COMMENTARYbaltimoresun.com
- FDA Issues Warning of Cancer Risk Linked to CAR-T TherapiesThe New York Times
- MFDA approves Reata's rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments3 min readmarketwatch.com
- BHealthcare Stocks, a Star Last Year, Are Stumbling Out of the Gate3 min readbarrons.com
- MWhat to know about the Alzheimer’s drug data coming out this week3 min readmarketwatch.com
- MOne Alzheimer's drug has failed, but investors are still betting on Biogen and Lilly treatments 2 min readmarketwatch.com
- MFDA approves new ALS drug that costs $158,000 a year2 min readmarketwatch.com
- MA small biotech says Pfizer infringed on its patent with Paxlovid2 min readmarketwatch.com
- Biogen seeks new chief, cuts Aduhelm spendingArkansas Online
- MBeset by challenges with its Alzheimer's disease drug, Biogen pivots3 min readmarketwatch.com
- Change at the top for Biogen after Alzheimer's drug flops - Tue, 03 May 2022 PSTapnews.com
- MFour drug makers raked in $14 billion in sales of COVID-19 treatments in 2021. How will they do this year?4 min readmarketwatch.com
- Biogen cuts the price tag on its Alzheimer’s drug in halfjournalrecord.com
- Biogen cutting cost of Alzheimer's drugnwaonline.com
- Biogen cuts the price for its Alzheimer’s drug in halfpressherald.com
- HBiogen Cuts the Price Tag on its Alzheimer’s Drug in Halfhamodia.com
- Biogen cuts the price tag on its Alzheimer's drug in half - Mon, 20 Dec 2021 PSTapnews.com
- Concerns grow over safety of Alzheimer's drug Aduhelm after death of patient who got the drugStar Tribune
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.